• Follow
  • Follow
  • Follow
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Advisors
    • Partnerships
  • Technology
    • Overview
    • Publications
  • Pipeline
    • Overview
    • EX937
    • EX14280 and EX14663
  • News & Events
    • Press Releases
    • Events
    • Alerts
  • Contact

Exxel Pharma to Participate in a “New to Virtual Investor” Segment

by jtcir-auto | Jan 31, 2025 | Press Releases

Live moderated video webcast on Wednesday, February 5th at 4:00 PM ET AURORA, CO / ACCESS Newswire / January 31, 2025 / Exxel Pharma (“Exxel” or the “Company”), a pharmaceutical company dedicated to developing novel therapeutics for the...

Recent Posts

  • Exxel Pharma Participates in the Virtual Investor “Top 5 for ’25” On-Demand Conference
  • Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
  • Exxel Pharma to Participate in a “New to Virtual Investor” Segment
  • Exxel Pharma to Participate in the Virtual Investor Lunch Break: The Exxel Opportunity
  • Exxel Pharma Provides Business Overview and Upcoming Milestones

Recent Comments

No comments to show.
  • About Us
  • Technology
  • Pipeline
  • News & Events
  • Contact
  • Follow
  • Follow
  • Follow

©2025 Exxel Pharma

Privacy Policy